Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Strattera
Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) primarily used to treat attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. It works by increasing the levels of norepinephrine, a neurotransmitter associated with attention and focus, in the brain. Atomoxetine is not a stimulant like other common ADHD medications.
Used to treat attention-deficit/hyperactivity disorder (ADHD).
Suicidal thoughts and behavior in children and adolescents.
Outcome:
Hypertensive crisis
Mechanism:
Increased norepinephrine levels
Outcome:
Increased blood pressure
Mechanism:
Blocking of beta-adrenergic receptors
Outcome:
Decreased atomoxetine absorption
Mechanism:
Changes in gastric pH
Most likely new formulation: Extended-release atomoxetine for once-weekly dosing (Year: 2026, 75% confidence)
Based on current usage trends and clinical trial data, there is a 90% likelihood that atomoxetine will maintain its current FDA approval status for ADHD treatment.
Selective Norepinephrine Reuptake Inhibitor (SNRI)
Benzyl Alcohol